image credit: Unsplash

FDA Coronavirus (COVID-19) Update

March 24, 2020


The U.S. Food and Drug Administration (FDA), on March 23, announced the following actions in its ongoing response effort to the COVID-19 pandemic:

• The FDA issued a safety alert for fecal microbiota transplantation (FMT) procedures. The FDA has issued a safety communication about the potential for transmission of the COVID-19 virus through FMT, a procedure that delivers human donor stool into the colon of a patient to treat c. difficile infection in patients that have not responded to standard therapies.

• The FDA also updated its recommendations regarding specimen collection for COVID-19 testing.

Read More on Contract Pharma